CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 03:39 (1519 d 13:02 ago) – Posting: # 18895
Views: 5,396

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

UA Flag
Activity
 Admin contact
22,292 posts in 4,666 threads, 1,584 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Wednesday 16:41 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5